结直肠癌中信号通路的研究进展

摘要/Abstract

中图分类号:

R735.3

付溶川, 周涛, 赵学荣, 王建平, 郑帅, 赵恩宏, 肖丽君. 结直肠癌中信号通路的研究进展[J]. 承德医学院学报, 2024, 41(3): 234-238.

[1] Aziz MA, Sarwar MS, Akter T, et al.Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer[J]. Life Sci, 2021, 1(268): 118999.
[2] Wang SW, Sun YM.The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review)[J]. Int J Oncol, 2014, 44(4): 1032-1040.
[3] Li X, Wen D, Li X, et al.Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer[J]. Front Immunol, 2020, 11: 1678.
[4] Wang S, Lei Y, Cai Z, et al.Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway[J]. Oncol Rep, 2018, 40(2): 599-608.
[5] Lin Q, Ling YB, Chen JW, et al.Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer[J]. Int J Oncol, 2018, 53(1): 246-256.
[6] Yao H, Su S, Xia D, et al.F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway[J]. Biomed Pharmacother, 2018, 107: 1712-1719.
[7] Takeda T, Yamamoto Y, Tsubaki M, et al.PI3K/Akt/YAP signaling promotes migration and invasion of DLD-1 colorectal cancer cells[J]. Oncol Lett, 2022, 23(4): 106.
[8] Wang L, Choi K, Su T, et al.Multiphase coalescence mediates Hippo pathway activation[J]. Cell, 2022, 185(23): 4376-4393.
[9] Moafian Z, Maghrouni A, Soltani A, et al.Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer[J]. Mol Biol Rep, 2021,48(5): 4797-4811.
[10] Wang Y, Xu X, Maglic D, et al.Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer[J]. Cell Rep, 2018, 25(5): 1304-1317.
[11] Sun Z, Zhang Q, Yuan W, et al.MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis[J]. J Exp Clin Cancer Res, 2020, 39(1): 250.
[12] Ren C, Yao Y, Han R, et al.Cerebral ischemia induces angiogenesis in the peri-infarct regions via Notch1 signaling activation[J]. Exp Neurol, 2018, 304: 30-40.
[13] Pal D, Tyagi A, Chandrasekaran B, et al.Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancer[J]. Cell Death Dis, 2018, 9(8): 798.
[14] Perez LG, Kempski J, McGee HM, et al. TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer[J]. Nat Commun, 2020, 11(1): 2608.
[15] Zhang B, Halder SK, Kashikar ND, et al.Antimetastatic role of Smad4 signaling in colorectal cancer[J]. Gastroenterology, 2010, 138(3): 969-980.
[16] Li J, Zou L, Zhou Y, et al.A low-frequency variant in SMAD7 modulates TGF-β signaling and confers risk for colorectal cancer in Chinese population[J]. Mol Carcinog, 2017, 56(7): 1798-1807.
[17] Tewari D, Bawari S, Sharma S, et al.Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy[J]. Pharmacol Ther, 2021, 227: 107876.
[18] Foerster EG, Mukherjee T, Cabral-Fernandes L, et al.How autophagy controls the intestinal epithelial barrier[J]. Autophagy, 2022, 18(1): 86-103.
[19] Zhang W, Ruan X, Li Y Z, et al.KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway[J]. Theranostics, 2022, 12(4): 1500-1517.
[20] Neiheisel A, Kaur M, Ma N, et al.Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials[J]. Int J Cancer, 2022, 150(5): 727-740.
[21] Zhang W, Ruan X, Li Y, et al.KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway[J]. Theranostics, 2022, 12(4): 1500-1517.
[22] Neiheisel A, Kaur M, Ma N, et al.Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials[J]. Int J Cancer, 2022, 150(5): 727-740.
[23] Jiang J.Hedgehog signaling mechanism and role in cancer[J]. Semin Cancer Biol, 2022, 85: 107-122.
[24] Niyaz M, Khan MS, Mudassar S.Hedgehog Signaling: An Achilles' Heel in Cancer[J]. Transl Oncol, 2019, 12(10): 1334-1344.
[25] Rallis G, Koletsa T, Saridaki Z, et al.Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer[J]. Anticancer Res, 2019, 39(4): 2129-2138.
[26] Liu XL, Zhang XT, Meng J, et al.ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways[J]. Oncotarget, 2017, 8(33): 54265-54276.
[27] Wang Y, Liu J, Qiu Y, et al.ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells[J]. Oncotarget, 2016, 7(15): 19897-909.
[28] 李东,朱长利,万玉峰. PI3K抑制剂ZSTK-474对结直肠癌细胞增殖和侵袭的影响[J]. 现代肿瘤医学,2020,28(4):548-552.
[29] Zhu L, Derijard B, Chakrabandhu K, et al.Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death[J]. Cancer Lett, 2014, 354(2): 355-64.
[30] Molife LR, Yan L, Vitfell-Rasmussen J, et al.Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors[J]. J Hematol Oncol, 2014, 7: 1.
[31] Cheng X, Xu X, Chen D, et al.Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer[J]. Biomed Pharmacother, 2019, 110: 473-481.
[32] Kukcinaviciute E, Jonusiene V, Sasnauskiene A, et al.Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116[J]. J Cell Biochem, 2018, 119(7): 5913-5920.
[33] Yu Z, Du J, Zhao Y, et al.A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling[J]. Cancer Lett, 2021, 498: 31-41.
[34] 丁志浩,张晓东. Notch信号通路在结直肠癌中的研究进展[J]. 现代医药卫生,2022,38(17):2933-2939.
[35] Li DD, Zhao CH, Ding HW, et al.A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo[J]. Cell Prolif, 2018, 51(5): e12480.
[36] Li Y, Wang Z, Jin J, et al.Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway[J]. Biochem Biophys Res Commun, 2020, 523(4): 947-953.
[37] 孙美琪,贺亚楠,焦宗林,等. Hedgehog信号通路与肿瘤的研究新进展[J]. 现代肿瘤医学,2019,27(21):3933-3937.
[38] Sekulic A, Migden MR, Basset-Seguin N, et al.Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study[J]. BMC Cancer, 2019, 19(1): 366.
[39] Zhuo M, Chen W, Shang S, et al.Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling[J]. Oncogene, 2020, 39(16): 3336-3353.

结直肠癌中信号通路的研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李雨欣, 韩思雨, 易梦雅, 李警耀, 陈志宏. 丝胶通过PI3K/Akt信号通路对受损INS-1细胞糖酵解的调控作用[J]. 承德医学院学报, 2024, 41(3): 181-184.
[2]	温璐雯, 冯琦, 霍明一, 柳新, 程玉, 郑纪宁. 槐耳通过PI3K/AKT信号通路诱导结直肠癌细胞凋亡[J]. 承德医学院学报, 2023, 40(6): 451-455.
[3]	王建平, 王小青, 赵学荣, 高亚贤, 杨岚, 肖丽君. lncRNA-AK093407通过EMT促进结直肠癌细胞增殖和转移[J]. 承德医学院学报, 2023, 40(5): 361-366.
[4]	李艳荣, 孔爱伟, 张梦平. 协同医护一体化干预对结直肠癌患者围术期的影响[J]. 承德医学院学报, 2023, 40(4): 313-317.
[5]	张超洁, 商亚珍. CREB与阿尔茨海默病[J]. 承德医学院学报, 2023, 40(3): 237-241.
[6]	徐彤, 程玉, 温璐雯, 冯琦, 郑纪宁. 牡荆素调控人结直肠癌细胞对奥沙利铂的敏感性[J]. 承德医学院学报, 2023, 40(1): 1-5.
[7]	李思锦, 周龙妹, 何培元. 结直肠癌筛查方法的依从性及成本效益的研究进展[J]. 承德医学院学报, 2023, 40(1): 60-64.
[8]	李璐, 黄艳洁, 郑纪宁. 华蟾素联合化疗治疗结直肠癌的疗效与安全性的系统评价[J]. 承德医学院学报, 2022, 39(2): 91-95.
[9]	祝盼盼, 商亚珍. MAPK信号通路介导细胞凋亡的研究进展[J]. 承德医学院学报, 2021, 38(3): 243-245.
[10]	刘欢, 刘莎莎, 申兴斌. Cx43和mTOR/p70S6K信号通路在胃癌中的研究进展[J]. 承德医学院学报, 2021, 38(1): 60-63.
[11]	李东哲, 王丹丹, 蔡明, 田甜, 杨东浩, 张宏. 糖尿病肾病影响因素及相关信号通路研究进展[J]. 承德医学院学报, 2020, 37(4): 333-336.
[12]	周丽丽, 刘赛璇, 赵杨, 刘莎莎, 王瑞婷, 申兴斌. 鬼臼苦素对人结直肠癌HCT-15细胞增殖的影响[J]. 承德医学院学报, 2018, 35(6): 457-460.
[13]	尚瑞国. 奥沙利铂联合雷替曲塞与FOLFOX4方案治疗晚期中老年结直肠癌疗效对比分析[J]. 承德医学院学报, 2018, 35(5): 383-385.
[14]	王颖川. 腹腔镜手术治疗对结直肠癌患者并发症和肛门功能的影响[J]. 承德医学院学报, 2018, 35(5): 397-398.
[15]	孙立园, 刘晓倩, 薛晶, 申兴斌. IGFBP-3、MMP-14在结直肠癌中的表达及临床意义[J]. 承德医学院学报, 2018, 35(2): 91-93.